New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
11:09 EDTGGB, MYL, TEVA, KSUOptions with increasing implied volatility: GGB MYL TEVA KSU
News For GGB;MYL;TEVA;KSU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 17, 2014
08:18 EDTKSUKansas City Southern: Economic outlook for 2014, 2015 positive for US, Mexico
Subscribe for More Information
08:04 EDTKSUKansas City Southern reaffirms updated 2014 goals
Subscribe for More Information
08:03 EDTKSUKansas City Southern reports Q3 adjusted EPS $1.29, consensus $1.26
Subscribe for More Information
October 16, 2014
15:26 EDTKSUNotable companies reporting before tomorrow's open
Subscribe for More Information
October 15, 2014
13:15 EDTKSURailroad stocks pressured after CSX CEO comments on industry consolidation
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research
07:14 EDTKSUUBS hosts a Railroad analyst/industry conference call
Analyst Wadewitz will discuss his initiation of coverage of the Railroad Sector in a conference call on October 14 at 11 am.
October 13, 2014
16:16 EDTKSUKansas City Southern initiated with a Neutral at UBS
Subscribe for More Information
10:53 EDTKSURailroads advance after report of Canadian Pacific approach to CSX
Subscribe for More Information
October 9, 2014
16:11 EDTTEVAAlexza reports 32,278 Adasuve units shipped to Teva in Q3
Subscribe for More Information
October 8, 2014
10:06 EDTKSUStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
08:05 EDTTEVATeva initiates NDA submission to FDA for CEP-33237
Teva Pharmaceutical announced the initiation of a rolling New Drug Application submission to the U.S. Food and Drug Administration for hydrocodone bitartrate extended-release tablets designed with Teva’s proprietary technology providing potential abuse-deterrent properties CEP-33237 as allowed for fast track designated products. Teva expects to complete the NDA submission by the end of 2014. Teva also announced positive results from a nasal Human Abuse Liability study which supports the NDA. The nasal HAL study found that in nondependent, recreational opioid users, abuse potential for crushed intranasal CEP-33237 was significantly lower than intranasal immediate-release hydrocodone. Teva has now completed positive HAL studies in the two most common routes of hydrocodone abuse, oral and intranasal. CEP-33237 demonstrated a safety profile in the Phase III study that is consistent with the known safety profile of hydrocodone and other opioid analgesic therapies. Adverse events reported in 5% or more of hydrocodone-treated patients during either the titration or double-blind treatment periods included nausea, constipation, vomiting, headache, somnolence and dizziness.
06:47 EDTMYL, TEVALawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link
October 7, 2014
10:56 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
October 6, 2014
11:58 EDTTEVATeva simplifaction plans expected but positive, says BMO Capital
Subscribe for More Information
11:09 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
08:32 EDTTEVATeva identifies 14 pipeline projects for discontinuation or divestment
Subscribe for More Information
08:32 EDTTEVATeva announces results of strategic review of core specialty therapeutic areas
Subscribe for More Information
07:30 EDTMYLMylan launches generic Combivir
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use